Post by: AngelOfThyNight on February 13, 2019, 02:58:30 PM
A ketamine-like drug for treatment-resistant depression was backed by a US Food and Drug Administration advisory committee on Tuesday. If it is then approved by the FDA, the drug -- called esketamine -- may provide a new option for patients with major depressive disorder who have tried at least two other antidepressants without success.
Source: Nasal spray depression treatment on track for FDA approval (http://rss.cnn.com/~r/rss/cnn_topstories/~3/tIA3bnaup5k/index.html)